Consistently, ITIH3, which has significant involvement in extracellular matrix remodeling during tumor progression, along with APOA1, APOE, APOL1, and CA19-9, constitutes a biomarker panel for pancreatic cancer [54]. The gene discussed is APOE; the disease is familial pancreatic carcinoma.